The Omega-MTB Genesis: A Cybernetic Constructor for the Deterministic Eradication of Mycobacterium tuberculosis

Title: The Omega-MTB Genesis: A Cybernetic Constructor for the Deterministic Eradication of Mycobacterium tuberculosis Description: Overview The Omega-MTB Genesis represents a fundamental paradigm shift in infectious disease management, transitioning from the probabilistic "wait-and-kill" methods of 2025-era pharmacology to a Deterministic Engineering framework. This research formalizes the Omega-Shield Framework, a structural evolution engine designed to truncate the traditional 180-day tuberculosis (TB) treatment cycle into a deterministic 14-day clinical operation. Architectural Core: The Double Digital Twin (DDT) At the heart of this system is a high-fidelity Double Digital Twin (DDT) that maps the symbiotic and parasitic interactions between Mycobacterium tuberculosis (Mtb) and the human host with absolute precision. Twin A (Pathogen Model): Models Mtb as an Active Inference Agent. It utilizes the Theorem of Tau-Evolution to derive the deterministic metabolic shifts of the pathogen, identifying early-phase effector proteins before they reach systemic detection thresholds. Twin B (Host Model): Architected as a Viable System Model (VSM) to detect "Systemic Disharmony" long before clinical symptoms emerge. This involves real-time monitoring of host biomarkers, including the Neutrophil-to-Lymphocyte Ratio (NLR) and Volatile Organic Compounds (VOCs). Technological Breakthroughs Quantum-Magnetic Molecular Resonance: The system utilizes the Axiome Omega Protocol to "tunnel" past the sensitivity limits of chemical reagents. By treating biological systems as a high-coherence "Big Atom," the system identifies pathognomonic Mtb "stains" (e.g., MPT64, SL-1, and C-type LAM fragments) at Day 1 (T=0) of infection. Silicon-Mycelium Rhizomatic Substrate: Delivery is executed via Engineered Living Materials (ELMs)—specifically a non-pathogenic fungal mycelium network integrated with a custom Silicon ASIC. This hybrid interface utilizes Mamba 2085 linear scaling to process fluidic resonance data in real-time on accessible hardware. Structural Zero Verification: Utilizing Cryo-Electron Tomography, the framework provides empirical proof of the total dissolution of the Arabinogalactan-Mycolic Acid (AG-MA) linkage within 72 hours (T+72). This breach restores instant susceptibility to baseline antibiotics, proving that Mtb resistance is primarily a physical shielding issue. Safety and Ethics The architecture incorporates a mandatory Primacy Credential Lock (PCL) to ensure human-in-the-loop sovereignty. To prevent environmental escape, the mycelial substrate is engineered with Synthetic Auxotrophy, making its survival dependent on a non-natural carbon "Omega-Fuel" pulse. Any growth anomaly triggers Programmed Autolysis within 180 minutes, ensuring absolute host safety. Clinical Impact By replacing stochastic outcomes with derived results, the Omega-MTB Genesis renders the 6-month "arborescent" era of TB treatment obsolete. It establishes the Digital Twin Operating System (DT-OS) as a new standard for human health, where medical outcomes are engineered rather than predicted. Keywords: Mycobacterium tuberculosis, Constructor Theory, Digital Twin, Mamba 2085, Engineered Living Materials, Mycelium-Silicon Interface, Quantum Resonance, Data Sovereignty.